- Division of Basic and Integrative Biological Sciences – DBIB
- Bioengineering Sciences and Technologies – BST
Dr. Joe Mosca’s career spans over 36 years in academics, biotechnology companies, and government. He has made noted contributions in areas of infectious diseases; gene therapy; CD28 co-stimulation; and mesenchymal stem cells. He has authored >50 peer-reviewed publications, 9 book chapters, and is an inventor on 11 U.S. patents with >33,000 scientific citations.
Dr. Mosca received his Ph.D. in biochemistry at Temple University, completed a postdoctoral fellowship in oncology at Johns Hopkins, and earned an MBA degree from Johns Hopkins Carey Business School. After 7 years at Hopkins with assistant professorships in oncology and infectious diseases, he joined the H.M. Jackson Foundation, where he continued with his gene therapy efforts in HIV/AIDS. In 1996, he moved from academia to biotechnology companies in tissue regeneration using adult mesenchymal stem cells and embryonic stem cells, and he aided the development of peptide-based HIV-entry inhibitors. In 2003, Dr. Mosca joined CSR as a Scientific Review Officer in the Infectious Diseases & Microbiology Integrated Review Group. He ran the Nanotechnology panel from 2007 to 2012.